Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Opinion in HIV and AIDS|October 28, 2010
The future of HIV vaccine research and the role of the Global HIV Vaccine EnterpriseYegor Voronin, Amapola Manrique, Alan BernsteinThe Lancet. Infectious Diseases|April 27, 2010
Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 ConferenceAnna Laura Ross, Andreas Bråve, Gabriella Scarlatti, et al.Plant Physiology|August 13, 2003
Molecular characterization of a novel lipase-like pathogen-inducible gene family of ArabidopsisGabor Jakab, Amapola Manrique, Laurent Zimmerli, et al.Blood|April 26, 2003
RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancementBranka Roscic-Mrkic, Marek Fischer, Christine Leemann, et al.Plos Medicine|November 24, 2006
Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infectionMichael Huber, Marek Fischer, Benjamin Misselwitz, et al.Journal of Virology|June 15, 2007
In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10Amapola Manrique, Peter Rusert, Beda Joos, et al.AIDS Research and Human Retroviruses|August 25, 2011
Measurements of immune responses for establishing correlates of vaccine protection against HIVWendy A Burgers, Amapola Manrique, David Masopust, et al.AIDS Research and Human Retroviruses|May 27, 2014
The immune space: a concept and template for rationalizing vaccine developmentAmapola Manrique, Elizabeth Adams, Dan H Barouch, et al.Nature Medicine|May 10, 2005
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodiesAlexandra Trkola, Herbert Kuster, Peter Rusert, et al.Microorganisms|April 3, 2021
High Efficacy of Saliva in Detecting SARS-CoV-2 by RT-PCR in Adults and ChildrenMichael Huber, Peter Werner Schreiber, Thomas Scheier, et al.Pageof 2